# FDA Panel Backs Peptide Drugs Despite Scientists' Warnings Health advisors recommend easing access to peptides. - **Source:** [Fast Company](https://www.fastcompany.com) - **Published:** 2026-07-24 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/e42f4dae-ec06-437b-9701-cdaab75d00ad ## FDA Panel Supports Peptide Drugs A panel of federal health advisors recommended easing access to peptides. This decision came despite warnings from government scientists that these chemicals have not been proven safe or effective. ## Access to Peptides Could Expand External experts advised the FDA to lift restrictions on the production of peptides like BPC-157, TB-500, and KPV in pharmacies. This move could make peptides more widely available. ## Panel's Decision Not Binding The panel's vote is not binding but could strengthen Health Secretary Robert F. Kennedy Jr.'s efforts to support peptide use. Kennedy has vowed to overturn FDA restrictions on peptides. ## Opportunity for Telehealth Companies If the FDA follows the panel's advice, telehealth companies could ramp up marketing of peptides for wellness and cosmetic purposes. This could create a new market in the industry. ## Panel's Composition Raises Questions The panel's vote reflected its unusual makeup. Before the meeting, several individuals with ties to the peptide industry, including doctors, pharmacists, and consultants, were added to the group, raising concerns about impartiality. ## Future of Peptides Remains Uncertain The panel's decision could shape the future of peptides. However, it remains unclear whether the FDA will follow the recommendation. This process will determine the role of peptides in the healthcare sector. ## Sources covering this story - https://www.fastcompany.com/91579318/peptide-drugs-popular-with-influencers-get-backed-by-fda-panel-despite-warnings-from-scientists — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._